Davita inc. provides commentary on covid-19 pandemic

Davita inc. provides commentary on the covid-19 pandemic.davita inc - screening every person who enters a davita center for symptoms and exposure to covid-19.davita inc - restricting entry to its clinics to only patients and medical professionals.davita inc - financial impacts of covid-19 on company were not felt until late into q1.davita inc - drew down $500 million from its available revolving credit facility in march.davita inc - currently expects no significant impact from covid-19 on q1 financial results.davita - sees short-term financial impact of covid-19 from increased costs, lost revenue, increase in treatment of uninsured, may be offset by cares act payment.davita inc - currently estimates increased revenue from suspension of 2% medicare sequestration from may 1, to dec 31, 2020 to be about $50 million.davita- co's future results could vary materially from guidance co provided.davita inc - potential impact of pandemic include likelihood of higher salary and wage expense from incremental hours and overtime.davita inc - potential impact of pandemic include likelihood of increased supply costs due to elevated demand nationwide for ppe.davita inc - sees likelihood of negative impact of covid-19 on revenue due to lower treatment volumes from patient hospitalizations, missed treatments, or deaths.
DVA Ratings Summary
DVA Quant Ranking